Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility.
Saved in:
| Title: | Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility. |
|---|---|
| Authors: | Wilmott JS; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Sydney Medical School, The University of Sydney, Sydney, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, Australia., Johansson PA; QIMR Berghofer Medical Research Institute, Brisbane, Australia., Newell F; QIMR Berghofer Medical Research Institute, Brisbane, Australia., Waddell N; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia., Ferguson P; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Sydney Medical School, The University of Sydney, Sydney, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, Australia.; Royal Prince Alfred Hospital, Camperdown, Australia., Quek C; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Sydney Medical School, The University of Sydney, Sydney, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, Australia., Patch AM; QIMR Berghofer Medical Research Institute, Brisbane, Australia., Nones K; QIMR Berghofer Medical Research Institute, Brisbane, Australia., Shang P; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Sydney Medical School, The University of Sydney, Sydney, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, Australia., Pritchard AL; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; The University of the Highlands and Islands, Inverness, United Kingdom., Kazakoff S; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia., Holmes O; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia., Leonard C; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia., Wood S; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia., Xu Q; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia., Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Sydney Medical School, The University of Sydney, Sydney, Australia.; Royal Prince Alfred Hospital, Camperdown, Australia., Spillane AJ; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Sydney Medical School, The University of Sydney, Sydney, Australia.; Royal North Shore Hospital, New South Wales, Australia., Stretch JR; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Sydney Medical School, The University of Sydney, Sydney, Australia., Shannon KF; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Sydney Medical School, The University of Sydney, Sydney, Australia.; Royal Prince Alfred Hospital, Camperdown, Australia.; Chris O'Brien Lifehouse, Royal Prince Alfred Hospital, Camperdown, Australia., Kefford RF; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Macquarie University, North Ryde, Australia., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Sydney Medical School, The University of Sydney, Sydney, Australia.; Royal North Shore Hospital, New South Wales, Australia., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Sydney Medical School, The University of Sydney, Sydney, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, Australia.; Royal North Shore Hospital, New South Wales, Australia., Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Sydney Medical School, The University of Sydney, Sydney, Australia.; Royal Prince Alfred Hospital, Camperdown, Australia., Pearson JV; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia., Mann GJ; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Sydney Medical School, The University of Sydney, Sydney, Australia.; Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, Australia., Hayward NK; QIMR Berghofer Medical Research Institute, Brisbane, Australia., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Sydney Medical School, The University of Sydney, Sydney, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, Australia.; Royal Prince Alfred Hospital, Camperdown, Australia. |
| Source: | International journal of cancer [Int J Cancer] 2019 Mar 01; Vol. 144 (5), pp. 1049-1060. Date of Electronic Publication: 2018 Nov 21. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
